US › Healthcare

TherapeuticsMD Inc (TXMD)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$2.180.00%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$869,000

Revenue YoY

-8.7%

Net profit

$155,000

Profit YoY

-71.9%

EPS

$0.01

Net margin

17.8%

Key statistics

Market cap

$25.0M

Forward P/E

2.3

P/B

0.92

Book value

$2.33

EPS (TTM)

$-0.03

52-week high

$2.95

52-week low

$0.99

50-day MA

$2.08

200-day MA

$2.08

Beta

0.65

Analyst view

Analysts rate TherapeuticsMD Inc a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $5.00.

Shareholding

Insiders

9.04%

Institutions

31.72%

Largest institutional holders

Fund	Stake
Rubric Capital Management LP	10.30%
Clearline Capital LP	5.49%
Vanguard Capital Management, LLC	3.06%
Tejara Capital Ltd	2.98%
ADAR1 Capital Management LLC	1.81%
Renaissance Technologies Corp	1.26%
Morgan Stanley - Brokerage Accounts	1.12%
BlackRock Inc	0.99%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for TherapeuticsMD Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.